The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1-Reference-Cited by-同舟云学术

The Distinct Alterations Produced in Cardiovascular Functions by Prednisolone and Nitro-prednisolone (NCX-1015) in the Rat Highlight a Causal Role for Endothelin-1

Published:2004-04-27 Issue:3 Volume:310 Page:1133-1141
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Di Filippo Clara,Rossi Francesco,Ongini Ennio,Del Soldato Piero,Perretti Mauro,D'Amico Michele

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference60 articles.

1. Synthesis of Nitro Esters of Prednisolone, New Compounds Combining Pharmacological Properties of Both Glucocorticoids and Nitric Oxide

2. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats.

3. Antihypertensive Effects of a Novel Endothelin-A Receptor Antagonist in Rats

4. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndrome;Pharmacogenomics;2019-02

2. Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury;Kidney International;2013-10

3. The Calcitonin and Glucocorticoids Combination: Mechanistic Insights into Their Class–Effect Synergy in Experimental Arthritis;PLoS ONE;2013-02-05

4. Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse;Equine Veterinary Journal;2010-01-05

5. NO donor hybrid compounds as multifunctional therapeutic agents;Expert Opinion on Therapeutic Patents;2008-10